These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32060415)

  • 1. The role of ceramides in metabolic disorders: when size and localization matters.
    Turpin-Nolan SM; Brüning JC
    Nat Rev Endocrinol; 2020 Apr; 16(4):224-233. PubMed ID: 32060415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of specific ceramides to obesity-associated metabolic diseases.
    Hammerschmidt P; Brüning JC
    Cell Mol Life Sci; 2022 Jul; 79(8):395. PubMed ID: 35789435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide Acyl Chain Length and Its Relevance to Intracellular Lipid Regulation.
    Ho QWC; Zheng X; Ali Y
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases.
    Raichur S
    Front Endocrinol (Lausanne); 2020; 11():483. PubMed ID: 32849276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramides - Lipotoxic Inducers of Metabolic Disorders.
    Chaurasia B; Summers SA
    Trends Endocrinol Metab; 2015 Oct; 26(10):538-550. PubMed ID: 26412155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramides in Metabolism: Key Lipotoxic Players.
    Chaurasia B; Summers SA
    Annu Rev Physiol; 2021 Feb; 83():303-330. PubMed ID: 33158378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum ceramides are linked with obesity-associated gut dysbiosis and impaired glucose metabolism.
    Kayser BD; Prifti E; Lhomme M; Belda E; Dao MC; Aron-Wisnewsky J; ; Kontush A; Zucker JD; Rizkalla SW; Dugail I; Clément K
    Metabolomics; 2019 Oct; 15(11):140. PubMed ID: 31605240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
    Park JW; Park WJ; Futerman AH
    Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of altered sphingolipid acyl chain length on various disease models.
    Park WJ; Park JW
    Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles and therapeutic potentials of sphingolipids in pathophysiology: emphasis on fatty acyl heterogeneity.
    Mu J; Lam SM; Shui G
    J Genet Genomics; 2024 Mar; 51(3):268-278. PubMed ID: 37364711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramides as modulators of cellular and whole-body metabolism.
    Bikman BT; Summers SA
    J Clin Invest; 2011 Nov; 121(11):4222-30. PubMed ID: 22045572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Click reactions with functional sphingolipids.
    Fink J; Seibel J
    Biol Chem; 2018 Sep; 399(10):1157-1168. PubMed ID: 29908120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ceramide-centric view of insulin resistance.
    Chavez JA; Summers SA
    Cell Metab; 2012 May; 15(5):585-94. PubMed ID: 22560211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramides are fuel gauges on the drive to cardiometabolic disease.
    Wilkerson JL; Tatum SM; Holland WL; Summers SA
    Physiol Rev; 2024 Jul; 104(3):1061-1119. PubMed ID: 38300524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development.
    García-González V; Díaz-Villanueva JF; Galindo-Hernández O; Martínez-Navarro I; Hurtado-Ureta G; Pérez-Arias AA
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long and the short of ceramides.
    Wattenberg BW
    J Biol Chem; 2018 Jun; 293(25):9922-9923. PubMed ID: 29934368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited monogenic defects of ceramide metabolism: Molecular bases and diagnoses.
    Dubot P; Sabourdy F; Rybova J; Medin JA; Levade T
    Clin Chim Acta; 2019 Aug; 495():457-466. PubMed ID: 31128082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.
    Brüggen B; Kremser C; Bickert A; Ebel P; Vom Dorp K; Schultz K; Dörmann P; Willecke K; Dedek K
    Eur J Neurosci; 2016 Jul; 44(1):1700-13. PubMed ID: 27086873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
    Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease.
    Nicholson RJ; Norris MK; Poss AM; Holland WL; Summers SA
    Annu Rev Nutr; 2022 Aug; 42():115-144. PubMed ID: 35584813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.